Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-03-17

Clinical Trial Update: Trial Comparing Duration of Analgesia After Popliteal Fossa Sciatiac Nerve Block With Ropivacaine 0.5% When Combined With Placebo, Dexamethasone 4mg or Dexamethasone 8 mg [NA]

View source ↗

Summary

The clinical trial NCT01641419, comparing duration of analgesia after popliteal fossa sciatic nerve block with ropivacaine 0.5% plus placebo or dexamethasone 4 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexamethasone 4 mg (dexamethasone)
  • Dexamethasone 8 mg (dexamethasone)
  • Ropivacaine 0.5% (ropivacaine)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Pain, Sciatic Block | NA | Status: WITHDRAWN